본문으로 건너뛰기
← 뒤로

Steady progress in the treatment of advanced prostate cancer: a year in review.

Current opinion in oncology 2026 Vol.38(3) p. 243-248 Prostate Cancer Treatment and Resear
OpenAlex 토픽 · Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment PARP inhibition in cancer therapy

Gourdin T

📝 환자 설명용 한 줄

[PURPOSE OF REVIEW] This review is designed to highlight recent research efforts to optimize treatment strategies in men with advanced prostate cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Theodore Stewart Gourdin (2026). Steady progress in the treatment of advanced prostate cancer: a year in review.. Current opinion in oncology, 38(3), 243-248. https://doi.org/10.1097/CCO.0000000000001237
MLA Theodore Stewart Gourdin. "Steady progress in the treatment of advanced prostate cancer: a year in review.." Current opinion in oncology, vol. 38, no. 3, 2026, pp. 243-248.
PMID 41920570

Abstract

[PURPOSE OF REVIEW] This review is designed to highlight recent research efforts to optimize treatment strategies in men with advanced prostate cancer.

[RECENT FINDINGS] In hopes of improving outcomes in men with advanced prostate cancer, recent trials have focused on intensifying therapy earlier in the disease course both in men with biochemical recurrence and those with oligometastatic disease. Further research efforts have looked to refine the use of radiopharmaceuticals, targeted therapy, and combinations of existing agents. Finally, systemic therapies with novel targets may expand options for men with treatment-refractory metastatic castration-resistant disease.

[SUMMARY] Ongoing research focuses on maximizing the benefits of existing therapies while exploring treatments with new mechanisms of action.

MeSH Terms

Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant